[The history of the pharmacotherapy of obesity]. [PDF]
Probl Endokrinol (Mosk)Berkovskaya MA +3 more
europepmc +1 more source
[Pathogenetically justified use in real clinical practice of vaginal estriol 0.5 mg in women of different ages]. [PDF]
Probl Endokrinol (Mosk)Andreeva EN +3 more
europepmc +1 more source
[Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms]. [PDF]
Probl Endokrinol (Mosk)Dvoryanchikov YV +3 more
europepmc +1 more source
[Vitamin D deficiency in overweight patients: current strategies and practical aspects]. [PDF]
Probl Endokrinol (Mosk)Karonova TL +13 more
europepmc +1 more source
[The role of an interdisciplinary approach to the treatment of patients with reduced ovarian reserve, premature ovarian insufficiency and mood disorders]. [PDF]
Probl Endokrinol (Mosk)Absatarova YS +5 more
europepmc +1 more source
[The use of TruCare III insulin pump in patients with type 1 diabetes mellitus]. [PDF]
Probl Endokrinol (Mosk)Barsukov IA, Demina AA.
europepmc +1 more source
[First experience using an aromatase inhibitor in combination with growth hormone to improve growth prognosis in a 14-year-old boy with growth hormone deficiency after treatment of craniopharyngioma. A case-report]. [PDF]
Probl Endokrinol (Mosk)Mazerkina NA +4 more
europepmc +1 more source
[Combination of macro-TSH and macroprolactinemia phenomena in a patient with autoimmune thyroiditis and vitiligo]. [PDF]
Probl Endokrinol (Mosk)Sazonova DV +6 more
europepmc +1 more source
[Level of reactive oxygen species production in peripheral blood monocytes in patients with Graves' disease after radioiodine therapy]. [PDF]
Probl Endokrinol (Mosk)Fomina DV +3 more
europepmc +1 more source